Cardiology

Female gender predictor of all-cause mortality after PCI

(HealthDay)—Female gender is an independent predictor of all-cause mortality after percutaneous coronary intervention (PCI), according to a study published in the Jan. 15 issue of The American Journal of Cardiology.

Cardiology

Deferred revascularization tied to poor outcomes in diabetes

(HealthDay)—For patients with diabetes mellitus (DM), deferred revascularization is associated with poor medium-term outcomes, according to a study published in the Nov. 1 issue of The American Journal of Cardiology.

Cardiology

Women have worse outcomes during 36 months after ACS

(HealthDay)—In a study published in the Nov. 1 issue of The American Journal of Cardiology, among patients with acute coronary syndrome (ACS), women were found to have a higher mortality rate than men during 36 months of ...

Cardiology

Results of ReACT Trial presented

A randomized evaluation of routine follow-up coronary angiography after percutaneous coronary intervention (PCI) found that there was no long-term clinical benefit compared to clinical follow-up alone among unselected patients ...

Immunology

Guidance for coronary patients with ASA/NSAID sensitivity

(HealthDay)—In patients with stable chronic ischemic heart disease (CIHD) and histories of nonsevere hypersensitivity reactions to acetylsalicylic acid (ASA)/nonsteroidal anti-inflammatory drugs (NSAIDs), an ASA challenge ...

Cardiology

Risks, benefits of cangrelor consistent in angina, ACS

(HealthDay)—For patients with stable angina (SA) or acute coronary syndrome (ACS), the benefits and risks of cangrelor are consistent, according to a study published in the Sept. 26 issue of JACC: Cardiovascular Interventions.

page 16 from 30